Total Payments
$6,195
2024 Payments
$294.32
Companies
21
Transactions
117
Medicare Patients
330
Medicare Billing
$79,852
Payment Breakdown by Category
Other$3,920 (63.3%)
Food & Beverage$2,213 (35.7%)
Travel$45.82 (0.7%)
Education$16.15 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,920 | 4 | 63.3% |
| Food and Beverage | $2,213 | 109 | 35.7% |
| Travel and Lodging | $45.82 | 1 | 0.7% |
| Education | $16.15 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $4,017 | 9 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $375.87 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $366.24 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $197.93 | 10 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $187.15 | 8 | $0 (2022) |
| Alkermes, Inc. | $174.61 | 6 | $0 (2019) |
| ABIOMED | $147.20 | 1 | $0 (2020) |
| Lundbeck LLC | $130.63 | 7 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $128.75 | 9 | $0 (2022) |
| ABBVIE INC. | $102.37 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $294.32 | 16 | Otsuka America Pharmaceutical, Inc. ($144.69) |
| 2023 | $252.87 | 14 | Janssen Pharmaceuticals, Inc ($75.51) |
| 2022 | $293.82 | 14 | Supernus Pharmaceuticals, Inc. ($92.88) |
| 2021 | $271.21 | 15 | Supernus Pharmaceuticals, Inc. ($94.27) |
| 2020 | $324.79 | 12 | ABIOMED ($147.20) |
| 2019 | $2,791 | 26 | Allergan Inc. ($2,260) |
| 2018 | $1,835 | 10 | Allergan Inc. ($1,720) |
| 2017 | $130.79 | 10 | Takeda Pharmaceuticals America, Inc. ($52.85) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Neuroscience | ||||||
| 07/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Neuroscience | ||||||
| 06/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: PSYCHIATRY | ||||||
| 04/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: PSYCHIATRY | ||||||
| 03/01/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Neuroscience | ||||||
| 01/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/08/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: PSYCHIATRY | ||||||
| 11/30/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Neuroscience | ||||||
| 11/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Neuroscience | ||||||
| 10/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.85 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 56 | 222 | $48,073 | $14,678 |
| 2022 | 2 | 38 | 181 | $33,744 | $11,787 |
| 2021 | 4 | 97 | 339 | $68,196 | $25,014 |
| 2020 | 5 | 139 | 410 | $81,185 | $28,374 |
Total Patients
330
Total Services
1,152
Medicare Billing
$79,852
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 90 | $22,300 | $6,754 | 30.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 20 | 93 | $15,438 | $4,312 | 27.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 39 | $10,335 | $3,611 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 87 | $18,140 | $6,985 | 38.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 19 | 94 | $15,604 | $4,802 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 114 | $22,800 | $10,800 | 47.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 25 | 129 | $21,414 | $6,725 | 31.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 33 | 78 | $20,670 | $6,453 | 31.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 18 | $3,312 | $1,036 | 31.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 126 | $25,200 | $9,670 | 38.4% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 33 | 179 | $29,714 | $9,657 | 32.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 42 | $11,844 | $4,530 | 38.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 35 | $9,275 | $2,863 | 30.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 25 | 28 | $5,152 | $1,654 | 32.1% |
About Dr. Mohammad Khan, MD
Dr. Mohammad Khan, MD is a Psychiatry healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528028032.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Khan, MD has received a total of $6,195 in payments from pharmaceutical and medical device companies, with $294.32 received in 2024. These payments were reported across 117 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,920).
As a Medicare-enrolled provider, Khan has provided services to 330 Medicare beneficiaries, totaling 1,152 services with total Medicare billing of $79,852. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Plano, TX
- Active Since 03/27/2006
- Last Updated 12/06/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1528028032
Products in Payments
- VRAYLAR (Drug) $4,120
- REXULTI (Drug) $380.19
- SPRAVATO (Drug) $319.54
- TRINTELLIX (Drug) $225.40
- QELBREE (Drug) $187.15
- Impella (Device) $147.20
- LATUDA (Drug) $128.75
- ARISTADA (Drug) $105.99
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $76.75
- INVEGA SUSTENNA (Drug) $56.33
- ABILIFY MAINTENA (Drug) $56.00
- CAPLYTA (Drug) $51.41
- ABILIFY MYCITE (Drug) $48.62
- Trintellix (Drug) $38.28
- Dyanavel XR (Drug) $37.62
- Azstarys (Drug) $30.95
- VIVITROL (Drug) $28.55
- RELEXXII (Drug) $24.89
- INGREZZA (Drug) $21.06
- Vivitrol 380 mg (Drug) $20.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Plano
Suresh Sureddi, M.d, M.D
Psychiatry — Payments: $2.3M
Psychiatry $2.3M
Dr. David Crumpacker, Md, MD
Psychiatry — Payments: $422,982
Psychiatry $422,982
Dr. Ronald Moomaw, D.o, D.O
Psychiatry — Payments: $113,022
Psychiatry $113,022
Dante Burgos, M.d, M.D
Psychiatry — Payments: $11,168
Psychiatry $11,168
Robert Benigar Jr, Md, MD
Psychiatry — Payments: $9,749
Psychiatry $9,749
Dr. Dan Steinfink, Md, MD
Psychiatry — Payments: $8,786
Psychiatry $8,786